ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blood Product Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-1089
Home | Market Reports | Health| Nursing
Global Blood Product Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Blood Product Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-1089
Report
June 2025
Pages:155
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Limited
BPL
Kedrion S p A
Grifols
Takeda
LFB Group
Biotest
Grifols S A
Octapharma AG
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya-Bio
Yuanda shuyang
Weiguang Bio
Nanyue Bio
KM Biologics

Blood Product Market Size

In 2024, the global market size of Blood Product was estimated to be worth US$ 35330 million and is forecast to reach approximately US$ 58200 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.

Blood Product Market

Blood Product Market

Blood Products are medical products derived from human blood and used for the treatment of various conditions. They include whole blood, blood components like red blood cells, platelets, and plasma, as well as plasma derivatives such as clotting factors and immunoglobulins. Blood products are essential in medical treatments, including surgeries, trauma care, and for patients with blood disorders, anemia, or immune deficiencies.
Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the Plasma Fractionation Technology market.
Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the Plasma Fractionation Technologyation market.
Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for Plasma Fractionation Technology to produce these therapies.
Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.
Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of Plasma Fractionation Technologyation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.
Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.
Stringent Regulatory Framework: Plasma Fractionation Technologyation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.
Complex Manufacturing Process: The Plasma Fractionation Technologyation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Plasma Fractionation Technology includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Plasma Fractionation Technology market.
North America is the largest consumption place, with a revenue market share nearly 40% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Plasma Fractionation Technology.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Blood Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Product.
The Blood Product market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Product companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Blood Product Market Report

Report Metric Details
Report Name Blood Product Market
Forecasted market size in 2031 approximately US$ 58200 million
CAGR 7.5%
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Blood Product in global and regional level.
  • Chapter 3: Detailed analysis of Blood Product company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Product revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Blood Product Market size in 2031?

Ans: The Blood Product Market size in 2031 will be approximately US$ 58200 million.

What is the Blood Product Market share by region?

Ans: North America is the largest consumption place, with a revenue market share nearly 40% in 2023.

Who are the main players in the Blood Product Market report?

Ans: The main players in the Blood Product Market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics

What are the Application segmentation covered in the Blood Product Market report?

Ans: The Applications covered in the Blood Product Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Blood Product Market report?

Ans: The Types covered in the Blood Product Market report are Albumin, Immunoglobulin, Clotting Factor, Others

Recommended Reports

Blood Components

Plasma Derived Products

Blood Market Technologies

1 Study Coverage
1.1 Blood Product Product Introduction
1.2 Market by Type
1.2.1 Global Blood Product Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Albumin
1.2.3 Immunoglobulin
1.2.4 Clotting Factor
1.2.5 Others
1.3 Market by Application
1.3.1 Global Blood Product Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Blood Product Market Size Estimates and Forecasts
2.2 Blood Product Market Size by Region: 2024 Versus 2031
2.2.1 Global Blood Product Revenue by Region: 2020-2025
2.2.2 Global Blood Product Revenue Forecast by Region (2026-2031)
2.2.3 Global Blood Product Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Blood Product Revenue by Type (2020-2031)
3.1.2 Global Blood Product Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Blood Product Revenue by Application (2020-2031)
3.2.2 Global Blood Product Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Albumin of Blood Product Revenue Market Share by Application
3.3.2 Immunoglobulin of Blood Product Revenue Market Share by Application
3.3.3 Clotting Factor of Blood Product Revenue Market Share by Application
3.3.4 Others of Blood Product Revenue Market Share by Application
4 Global Blood Product by Company
4.1 Global Blood Product Revenue by Company (2020-2025)
4.2 Global Blood Product Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Blood Product Companies around the World: Ranking by Revenue
4.3.2 Global Blood Product Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Blood Product Companies Headquarters & Product Type
4.4.1 Global Blood Product Companies Headquarters
4.4.2 Date of International Companies Enter into Blood Product Market
4.4.3 Global Blood Product Companies Product & Service
4.4.4 Albumin Revenue Market Share of Blood Product by Company
4.4.5 Immunoglobulin Revenue Market Share of Blood Product by Company
4.4.6 Clotting Factor Revenue Market Share of Blood Product by Company
4.4.7 Others Revenue Market Share of Blood Product by Company
4.5 Global Blood Product Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Takeda
5.1.1 Takeda Corporation Information
5.1.2 Takeda Description, Business Overview
5.1.3 Takeda Blood Product Products Offered
5.1.4 Takeda Blood Product Revenue and Gross Margin (2020-2025)
5.1.5 Takeda Blood Product Revenue by Product in 2024
5.1.6 Takeda Blood Product Revenue by Application in 2024
5.1.7 Takeda Blood Product Revenue by Geographic Area in 2024
5.1.8 Takeda Recent Developments
5.2 CSL
5.2.1 CSL Corporation Information
5.2.2 CSL Description, Business Overview
5.2.3 CSL Blood Product Products Offered
5.2.4 CSL Blood Product Revenue and Gross Margin (2020-2025)
5.2.5 CSL Blood Product Revenue by Product in 2024
5.2.6 CSL Blood Product Revenue by Application in 2024
5.2.7 CSL Blood Product Revenue by Geographic Area in 2024
5.2.8 CSL Recent Developments
5.3 Grifols
5.3.1 Grifols Corporation Information
5.3.2 Grifols Description, Business Overview
5.3.3 Grifols Blood Product Products Offered
5.3.4 Grifols Blood Product Revenue and Gross Margin (2020-2025)
5.3.5 Grifols Blood Product Revenue by Product in 2024
5.3.6 Grifols Blood Product Revenue by Application in 2024
5.3.7 Grifols Blood Product Revenue by Geographic Area in 2024
5.3.8 Grifols Recent Developments
5.4 Octapharma
5.4.1 Octapharma Corporation Information
5.4.2 Octapharma Description, Business Overview
5.4.3 Octapharma Blood Product Products Offered
5.4.4 Octapharma Blood Product Revenue and Gross Margin (2020-2025)
5.4.5 Octapharma Blood Product Revenue by Product in 2024
5.4.6 Octapharma Blood Product Revenue by Application in 2024
5.4.7 Octapharma Blood Product Revenue by Geographic Area in 2024
5.4.8 Octapharma Recent Developments
5.5 Kedrion
5.5.1 Kedrion Corporation Information
5.5.2 Kedrion Description, Business Overview
5.5.3 Kedrion Blood Product Products Offered
5.5.4 Kedrion Blood Product Revenue and Gross Margin (2020-2025)
5.5.5 Kedrion Blood Product Revenue by Product in 2024
5.5.6 Kedrion Blood Product Revenue by Application in 2024
5.5.7 Kedrion Blood Product Revenue by Geographic Area in 2024
5.5.8 Kedrion Recent Developments
5.6 LFB Group
5.6.1 LFB Group Corporation Information
5.6.2 LFB Group Description, Business Overview
5.6.3 LFB Group Blood Product Products Offered
5.6.4 LFB Group Blood Product Revenue and Gross Margin (2020-2025)
5.6.5 LFB Group Blood Product Revenue by Product in 2024
5.6.6 LFB Group Blood Product Revenue by Application in 2024
5.6.7 LFB Group Blood Product Revenue by Geographic Area in 2024
5.6.8 LFB Group Recent Developments
5.7 Biotest
5.7.1 Biotest Corporation Information
5.7.2 Biotest Description, Business Overview
5.7.3 Biotest Blood Product Products Offered
5.7.4 Biotest Blood Product Revenue and Gross Margin (2020-2025)
5.7.5 Biotest Blood Product Revenue by Product in 2024
5.7.6 Biotest Blood Product Revenue by Application in 2024
5.7.7 Biotest Blood Product Revenue by Geographic Area in 2024
5.7.8 Biotest Recent Developments
5.8 BPL
5.8.1 BPL Corporation Information
5.8.2 BPL Description, Business Overview
5.8.3 BPL Blood Product Products Offered
5.8.4 BPL Blood Product Revenue and Gross Margin (2020-2025)
5.8.5 BPL Blood Product Revenue by Product in 2024
5.8.6 BPL Blood Product Revenue by Application in 2024
5.8.7 BPL Blood Product Revenue by Geographic Area in 2024
5.8.8 BPL Recent Developments
5.9 RAAS
5.9.1 RAAS Corporation Information
5.9.2 RAAS Description, Business Overview
5.9.3 RAAS Blood Product Products Offered
5.9.4 RAAS Blood Product Revenue and Gross Margin (2020-2025)
5.9.5 RAAS Blood Product Revenue by Product in 2024
5.9.6 RAAS Blood Product Revenue by Application in 2024
5.9.7 RAAS Blood Product Revenue by Geographic Area in 2024
5.9.8 RAAS Recent Developments
5.10 CBPO
5.10.1 CBPO Corporation Information
5.10.2 CBPO Description, Business Overview
5.10.3 CBPO Blood Product Products Offered
5.10.4 CBPO Blood Product Revenue and Gross Margin (2020-2025)
5.10.5 CBPO Blood Product Revenue by Product in 2024
5.10.6 CBPO Blood Product Revenue by Application in 2024
5.10.7 CBPO Blood Product Revenue by Geographic Area in 2024
5.10.8 CBPO Recent Developments
5.11 Hualan Bio
5.11.1 Hualan Bio Corporation Information
5.11.2 Hualan Bio Description, Business Overview
5.11.3 Hualan Bio Blood Product Products Offered
5.11.4 Hualan Bio Blood Product Revenue and Gross Margin (2020-2025)
5.11.5 Hualan Bio Blood Product Revenue by Product in 2024
5.11.6 Hualan Bio Blood Product Revenue by Application in 2024
5.11.7 Hualan Bio Blood Product Revenue by Geographic Area in 2024
5.11.8 Hualan Bio Recent Developments
5.12 Tiantan Bio
5.12.1 Tiantan Bio Corporation Information
5.12.2 Tiantan Bio Description, Business Overview
5.12.3 Tiantan Bio Blood Product Products Offered
5.12.4 Tiantan Bio Blood Product Revenue and Gross Margin (2020-2025)
5.12.5 Tiantan Bio Blood Product Revenue by Product in 2024
5.12.6 Tiantan Bio Blood Product Revenue by Application in 2024
5.12.7 Tiantan Bio Blood Product Revenue by Geographic Area in 2024
5.12.8 Tiantan Bio Recent Developments
5.13 Shuanglin Bio
5.13.1 Shuanglin Bio Corporation Information
5.13.2 Shuanglin Bio Description, Business Overview
5.13.3 Shuanglin Bio Blood Product Products Offered
5.13.4 Shuanglin Bio Blood Product Revenue and Gross Margin (2020-2025)
5.13.5 Shuanglin Bio Blood Product Revenue by Product in 2024
5.13.6 Shuanglin Bio Blood Product Revenue by Application in 2024
5.13.7 Shuanglin Bio Blood Product Revenue by Geographic Area in 2024
5.13.8 Shuanglin Bio Recent Developments
5.14 Boya Bio
5.14.1 Boya Bio Corporation Information
5.14.2 Boya Bio Description, Business Overview
5.14.3 Boya Bio Blood Product Products Offered
5.14.4 Boya Bio Blood Product Revenue and Gross Margin (2020-2025)
5.14.5 Boya Bio Blood Product Revenue by Product in 2024
5.14.6 Boya Bio Blood Product Revenue by Application in 2024
5.14.7 Boya Bio Blood Product Revenue by Geographic Area in 2024
5.14.8 Boya Bio Recent Developments
5.15 Yuanda Shuyang
5.15.1 Yuanda Shuyang Corporation Information
5.15.2 Yuanda Shuyang Description, Business Overview
5.15.3 Yuanda Shuyang Blood Product Products Offered
5.15.4 Yuanda Shuyang Blood Product Revenue and Gross Margin (2020-2025)
5.15.5 Yuanda Shuyang Blood Product Revenue by Product in 2024
5.15.6 Yuanda Shuyang Blood Product Revenue by Application in 2024
5.15.7 Yuanda Shuyang Blood Product Revenue by Geographic Area in 2024
5.15.8 Yuanda Shuyang Recent Developments
5.16 Weiguang Bio
5.16.1 Weiguang Bio Corporation Information
5.16.2 Weiguang Bio Description, Business Overview
5.16.3 Weiguang Bio Blood Product Products Offered
5.16.4 Weiguang Bio Blood Product Revenue and Gross Margin (2020-2025)
5.16.5 Weiguang Bio Blood Product Revenue by Product in 2024
5.16.6 Weiguang Bio Blood Product Revenue by Application in 2024
5.16.7 Weiguang Bio Blood Product Revenue by Geographic Area in 2024
5.16.8 Weiguang Bio Recent Developments
5.17 Nanyue Bio
5.17.1 Nanyue Bio Corporation Information
5.17.2 Nanyue Bio Description, Business Overview
5.17.3 Nanyue Bio Blood Product Products Offered
5.17.4 Nanyue Bio Blood Product Revenue and Gross Margin (2020-2025)
5.17.5 Nanyue Bio Blood Product Revenue by Product in 2024
5.17.6 Nanyue Bio Blood Product Revenue by Application in 2024
5.17.7 Nanyue Bio Blood Product Revenue by Geographic Area in 2024
5.17.8 Nanyue Bio Recent Developments
5.18 KM Biologics
5.18.1 KM Biologics Corporation Information
5.18.2 KM Biologics Description, Business Overview
5.18.3 KM Biologics Blood Product Products Offered
5.18.4 KM Biologics Blood Product Revenue and Gross Margin (2020-2025)
5.18.5 KM Biologics Blood Product Revenue by Product in 2024
5.18.6 KM Biologics Blood Product Revenue by Application in 2024
5.18.7 KM Biologics Blood Product Revenue by Geographic Area in 2024
5.18.8 KM Biologics Recent Developments
6 North America
6.1 North America Blood Product Market Size YoY Growth 2020-2031
6.2 North America Blood Product Market Facts & Figures by Country (2020-2031)
6.3 North America Blood Product Revenue by Type (2020-2025)
6.4 North America Blood Product Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Blood Product Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Blood Product Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Blood Product Revenue by Type (2020-2025)
7.4 Asia-Pacific Blood Product Revenue by Application (2020-2025)
8 Europe
8.1 Europe Blood Product Market Size YoY Growth 2020-2031
8.2 Europe Blood Product Market Facts & Figures by Country (2020-2031)
8.3 Europe Blood Product Revenue by Type (2020-2025)
8.4 Europe Blood Product Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Blood Product Market Size YoY Growth 2020-2031
9.2 Latin America Blood Product Market Facts & Figures by Country (2020-2031)
9.3 Latin America Blood Product Revenue by Type (2020-2025)
9.4 Latin America Blood Product Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Blood Product Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Blood Product Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Blood Product Revenue by Type (2020-2025)
10.4 Middle East and Africa Blood Product Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Blood Product Supply Chain Analysis
11.2 Blood Product Key Raw Materials and Upstream Suppliers
11.3 Blood Product Clients Analysis
11.4 Blood Product Sales Channel and Sales Model Analysis
11.4.1 Blood Product Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Blood Product Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Blood Product Distributors
12 Blood Product Market Dynamics
12.1 Blood Product Industry Trends
12.2 Blood Product Market Drivers
12.3 Blood Product Market Challenges
12.4 Blood Product Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
CSL Limited
BPL
Kedrion S p A
Grifols
Takeda
LFB Group
Biotest
Grifols S A
Octapharma AG
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya-Bio
Yuanda shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
List of Tables
 Table 1. Global Blood Product Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Blood Product Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Blood Product Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Blood Product Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Blood Product Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Blood Product Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Blood Product Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Blood Product Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Blood Product Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Blood Product Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Blood Product Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Blood Product Players by Revenue (US$ Million) in 2024
 Table 13. Global Blood Product Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Product as of 2024)
 Table 15. Global Blood Product Companies Headquarters
 Table 16. Date of International Companies Enter into Blood Product Market
 Table 17. Global Blood Product Companies Product & Service
 Table 18. Global Blood Product Mergers & Acquisitions, Expansion Plans
 Table 19. Takeda Corporation Information
 Table 20. Takeda Description and Business Overview
 Table 21. Takeda Blood Product Product
 Table 22. Takeda Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Takeda Revenue Proportion of Blood Product by Product in 2024
 Table 24. Takeda Revenue Proportion of Blood Product by Application in 2024
 Table 25. Takeda Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 26. Takeda Recent Developments
 Table 27. CSL Corporation Information
 Table 28. CSL Description and Business Overview
 Table 29. CSL Blood Product Product
 Table 30. CSL Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. CSL Revenue Proportion of Blood Product by Product in 2024
 Table 32. CSL Revenue Proportion of Blood Product by Application in 2024
 Table 33. CSL Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 34. CSL Recent Developments
 Table 35. Grifols Corporation Information
 Table 36. Grifols Description and Business Overview
 Table 37. Grifols Blood Product Product
 Table 38. Grifols Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Grifols Revenue Proportion of Blood Product by Product in 2024
 Table 40. Grifols Revenue Proportion of Blood Product by Application in 2024
 Table 41. Grifols Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 42. Grifols Recent Developments
 Table 43. Octapharma Corporation Information
 Table 44. Octapharma Description and Business Overview
 Table 45. Octapharma Blood Product Product
 Table 46. Octapharma Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Octapharma Revenue Proportion of Blood Product by Product in 2024
 Table 48. Octapharma Revenue Proportion of Blood Product by Application in 2024
 Table 49. Octapharma Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 50. Octapharma Recent Developments
 Table 51. Kedrion Corporation Information
 Table 52. Kedrion Description and Business Overview
 Table 53. Kedrion Blood Product Product
 Table 54. Kedrion Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Kedrion Revenue Proportion of Blood Product by Product in 2024
 Table 56. Kedrion Revenue Proportion of Blood Product by Application in 2024
 Table 57. Kedrion Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 58. Kedrion Recent Developments
 Table 59. LFB Group Corporation Information
 Table 60. LFB Group Description and Business Overview
 Table 61. LFB Group Blood Product Product
 Table 62. LFB Group Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. LFB Group Revenue Proportion of Blood Product by Product in 2024
 Table 64. LFB Group Revenue Proportion of Blood Product by Application in 2024
 Table 65. LFB Group Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 66. LFB Group Recent Developments
 Table 67. Biotest Corporation Information
 Table 68. Biotest Description and Business Overview
 Table 69. Biotest Blood Product Product
 Table 70. Biotest Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Biotest Revenue Proportion of Blood Product by Product in 2024
 Table 72. Biotest Revenue Proportion of Blood Product by Application in 2024
 Table 73. Biotest Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 74. Biotest Recent Developments
 Table 75. BPL Corporation Information
 Table 76. BPL Description and Business Overview
 Table 77. BPL Blood Product Product
 Table 78. BPL Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. BPL Revenue Proportion of Blood Product by Product in 2024
 Table 80. BPL Revenue Proportion of Blood Product by Application in 2024
 Table 81. BPL Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 82. BPL Recent Developments
 Table 83. RAAS Corporation Information
 Table 84. RAAS Description and Business Overview
 Table 85. RAAS Blood Product Product
 Table 86. RAAS Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. RAAS Revenue Proportion of Blood Product by Product in 2024
 Table 88. RAAS Revenue Proportion of Blood Product by Application in 2024
 Table 89. RAAS Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 90. RAAS Recent Developments
 Table 91. CBPO Corporation Information
 Table 92. CBPO Description and Business Overview
 Table 93. CBPO Blood Product Product
 Table 94. CBPO Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. CBPO Revenue Proportion of Blood Product by Product in 2024
 Table 96. CBPO Revenue Proportion of Blood Product by Application in 2024
 Table 97. CBPO Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 98. CBPO Recent Developments
 Table 99. Hualan Bio Corporation Information
 Table 100. Hualan Bio Description and Business Overview
 Table 101. Hualan Bio Blood Product Product
 Table 102. Hualan Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Hualan Bio Revenue Proportion of Blood Product by Product in 2024
 Table 104. Hualan Bio Revenue Proportion of Blood Product by Application in 2024
 Table 105. Hualan Bio Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 106. Hualan Bio Recent Developments
 Table 107. Tiantan Bio Corporation Information
 Table 108. Tiantan Bio Description and Business Overview
 Table 109. Tiantan Bio Blood Product Product
 Table 110. Tiantan Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. Tiantan Bio Revenue Proportion of Blood Product by Product in 2024
 Table 112. Tiantan Bio Revenue Proportion of Blood Product by Application in 2024
 Table 113. Tiantan Bio Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 114. Tiantan Bio Recent Developments
 Table 115. Shuanglin Bio Corporation Information
 Table 116. Shuanglin Bio Description and Business Overview
 Table 117. Shuanglin Bio Blood Product Product
 Table 118. Shuanglin Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. Shuanglin Bio Revenue Proportion of Blood Product by Product in 2024
 Table 120. Shuanglin Bio Revenue Proportion of Blood Product by Application in 2024
 Table 121. Shuanglin Bio Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 122. Shuanglin Bio Recent Developments
 Table 123. Boya Bio Corporation Information
 Table 124. Boya Bio Description and Business Overview
 Table 125. Boya Bio Blood Product Product
 Table 126. Boya Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 127. Boya Bio Revenue Proportion of Blood Product by Product in 2024
 Table 128. Boya Bio Revenue Proportion of Blood Product by Application in 2024
 Table 129. Boya Bio Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 130. Boya Bio Recent Developments
 Table 131. Yuanda Shuyang Corporation Information
 Table 132. Yuanda Shuyang Description and Business Overview
 Table 133. Yuanda Shuyang Blood Product Product
 Table 134. Yuanda Shuyang Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 135. Yuanda Shuyang Revenue Proportion of Blood Product by Product in 2024
 Table 136. Yuanda Shuyang Revenue Proportion of Blood Product by Application in 2024
 Table 137. Yuanda Shuyang Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 138. Yuanda Shuyang Recent Developments
 Table 139. Weiguang Bio Corporation Information
 Table 140. Weiguang Bio Description and Business Overview
 Table 141. Weiguang Bio Blood Product Product
 Table 142. Weiguang Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Weiguang Bio Revenue Proportion of Blood Product by Product in 2024
 Table 144. Weiguang Bio Revenue Proportion of Blood Product by Application in 2024
 Table 145. Weiguang Bio Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 146. Weiguang Bio Recent Developments
 Table 147. Nanyue Bio Corporation Information
 Table 148. Nanyue Bio Description and Business Overview
 Table 149. Nanyue Bio Blood Product Product
 Table 150. Nanyue Bio Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 151. Nanyue Bio Revenue Proportion of Blood Product by Product in 2024
 Table 152. Nanyue Bio Revenue Proportion of Blood Product by Application in 2024
 Table 153. Nanyue Bio Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 154. Nanyue Bio Recent Developments
 Table 155. KM Biologics Corporation Information
 Table 156. KM Biologics Description and Business Overview
 Table 157. KM Biologics Blood Product Product
 Table 158. KM Biologics Blood Product Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 159. KM Biologics Revenue Proportion of Blood Product by Product in 2024
 Table 160. KM Biologics Revenue Proportion of Blood Product by Application in 2024
 Table 161. KM Biologics Revenue Proportion of Blood Product by Geographic Area in 2024
 Table 162. KM Biologics Recent Developments
 Table 163. North America Blood Product Revenue by Country (2020-2025) & (US$ Million)
 Table 164. North America Blood Product Revenue by Country (2026-2031) & (US$ Million)
 Table 165. North America Blood Product Revenue by Type (2020-2025) & (US$ Million)
 Table 166. North America Blood Product Revenue by Application (2020-2025) & (US$ Million)
 Table 167. Asia-Pacific Blood Product Revenue by Region (2020-2025) & (US$ Million)
 Table 168. Asia-Pacific Blood Product Revenue by Region (2026-2031) & (US$ Million)
 Table 169. Asia-Pacific Blood Product Revenue by Type (2020-2025) & (US$ Million)
 Table 170. Asia-Pacific Blood Product Revenue by Application (2020-2025) & (US$ Million)
 Table 171. Europe Blood Product Revenue by Country (2020-2025) & (US$ Million)
 Table 172. Europe Blood Product Revenue by Country (2026-2031) & (US$ Million)
 Table 173. Europe Blood Product Revenue by Type (2020-2025) & (US$ Million)
 Table 174. Europe Blood Product Revenue by Application (2020-2025) & (US$ Million)
 Table 175. Latin America Blood Product Revenue by Country (2020-2025) & (US$ Million)
 Table 176. Latin America Blood Product Revenue by Country (2026-2031) & (US$ Million)
 Table 177. Latin America Blood Product Revenue by Type (2020-2025) & (US$ Million)
 Table 178. Latin America Blood Product Revenue by Application (2020-2025) & (US$ Million)
 Table 179. Middle East and Africa Blood Product Revenue by Country (2020-2025) & (US$ Million)
 Table 180. Middle East and Africa Blood Product Revenue by Country (2026-2031) & (US$ Million)
 Table 181. Middle East and Africa Blood Product Revenue by Type (2020-2025) & (US$ Million)
 Table 182. Middle East and Africa Blood Product Revenue by Application (2020-2025) & (US$ Million)
 Table 183. Blood Product Key Raw Materials, Industry Status and Trend
 Table 184. Blood Product Key Raw Materials and Upstream Suppliers
 Table 185. Blood Product Clients Status and Trend
 Table 186. Blood Product Typical Clients
 Table 187. Blood Product Distributors
 Table 188. Blood Product Market Trends
 Table 189. Blood Product Market Drivers
 Table 190. Blood Product Market Challenges
 Table 191. Blood Product Market Restraints
 Table 192. Research Programs/Design for This Report
 Table 193. Key Data Information from Secondary Sources
 Table 194. Key Data Information from Primary Sources


List of Figures
 Figure 1. Blood Product Product Picture
 Figure 2. Global Blood Product Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Blood Product Revenue Market Share by Type in 2024 & 2031
 Figure 4. Albumin Product Picture
 Figure 5. Immunoglobulin Product Picture
 Figure 6. Clotting Factor Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Blood Product Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 9. Global Blood Product Revenue Market Share by Application in 2024 & 2031
 Figure 10. Hospital
 Figure 11. Retail Pharmacy
 Figure 12. Other
 Figure 13. Blood Product Report Years Considered
 Figure 14. Global Blood Product Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Blood Product Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Blood Product Market Size Market Share by Region: 2024 Versus 2031
 Figure 17. Global Blood Product Revenue Market Share by Region (2020-2031)
 Figure 18. Global Blood Product Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Global Blood Product Revenue Market Share Forecast by Application (2020-2031)
 Figure 20. Albumin of Blood Product Revenue Market Share by Application, 2024 VS 2031
 Figure 21. Immunoglobulin of Blood Product Revenue Market Share by Application, 2024 VS 2031
 Figure 22. Clotting Factor of Blood Product Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Others of Blood Product Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Blood Product Revenue Share by Company (2024)
 Figure 25. Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Albumin Revenue Proportion by Company in 2024
 Figure 27. Immunoglobulin Revenue Proportion by Company in 2024
 Figure 28. Clotting Factor Revenue Proportion by Company in 2024
 Figure 29. Others Revenue Proportion by Company in 2024
 Figure 30. North America Blood Product Revenue 2020-2031 (US$ Million)
 Figure 31. North America Blood Product Revenue Market Share by Type (2020-2025)
 Figure 32. North America Blood Product Revenue Market Share by Application (2020-2025)
 Figure 33. Asia-Pacific Blood Product Revenue 2020-2031 (US$ Million)
 Figure 34. Asia-Pacific Blood Product Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Blood Product Revenue Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Blood Product Revenue Market Share by Application (2020-2025)
 Figure 37. Europe Blood Product Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Blood Product Revenue Market Share by Country (2020-2031)
 Figure 39. Europe Blood Product Revenue Market Share by Type (2020-2025)
 Figure 40. Europe Blood Product Revenue Market Share by Application (2020-2025)
 Figure 41. Latin America Blood Product Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America Blood Product Revenue Market Share by Country (2020-2031)
 Figure 43. Latin America Blood Product Revenue Market Share by Type (2020-2025)
 Figure 44. Latin America Blood Product Revenue Market Share by Application (2020-2025)
 Figure 45. Middle East and Africa Blood Product Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 46. Middle East and Africa Blood Product Revenue Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Blood Product Revenue Market Share by Type (2020-2025)
 Figure 48. Middle East and Africa Blood Product Revenue Market Share by Application (2020-2025)
 Figure 49. Blood Product Supply Chain (Upstream and Downstream Market)
 Figure 50. Global Production Market Share of Blood Product Raw Materials by Region in 2024
 Figure 51. Blood Product Distribution Channels
 Figure 52. Global Blood Product Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 53. Global Blood Product Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Human Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Biological Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plasma derived Medical Product Market Research Report 2025
Global Human Plasma Protein Products Market Research Report 2024
Human Plasma Products and Derivatives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasma derived Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Plasma Fractionation Product Market Research Report 2024
Global Human Blood Products Market Research Report 2025
Plasma Fractionation and Blood Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Blood Plasma Fractionation Market Research Report 2025
Global Blood Plasma Fractionation Market Research Report 2025
Fractionated Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasma Fractionation Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plasma Fractionation Market Research Report 2025
Global Blood Plasma Fractionation Technology Market Research Report 2025
Blood Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Blood and Blood Components Market Insights Forecast to 2030
Global Plasma Fractionation Technology Market Research Report 2025
Plasma for Fractionation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plasma Protein Therapeutics Market Research Report 2025

RELATED REPORTS

Global Persistent Epithelial Defect Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2O19977
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Intelligent Elderly Care Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E8132
Wed Sep 17 00:00:00 UTC 2025

Add to Cart

Global Radiation Monitoring Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23I7304
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Ophthalmology Homeopathic Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8T5982
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions